
Ying Huang, Legend Biotech CEO
Legend to double Carvykti production as it targets blockbuster status
Unlocking manufacturing capacity will be key for Legend Biotech and Johnson and Johnson in achieving their goal of reaching “blockbuster status” for Carvykti in 2025 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.